Richard John Yarwood

Richard John Yarwood currently works at Surepharm Services Ltd., as Director from 2022.
Dr. Yarwood also formerly worked at Penn Pharmaceutical Services Ltd., as Chief Executive Officer from 2010 to 2012, ChargePoint Technology Ltd., as Non-Executive Chairman, Consort Medical Ltd., as Commercial Director, Catalent Pharma Solutions Ltd., as Managing Director, Wellcome Plc, as Principal, Pfizer Group Ltd., as Principal, Catalent Pharma Solutions, Inc., as President-Sterile Technologies Segment from 1987 to 2009, Merck Life Science UK Ltd., as Principal, and Wyeth Europa Ltd., as Principal.
Dr. Yarwood received his doctorate degree from The University of Manchester, undergraduate degree from The University of Nottingham, and Masters Business Admin degree from the University of Warwick.